Middletown, DE -- (SBWIRE) -- 09/26/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Keryx Biopharmaceuticals (NASDAQ:KERX), Polycom Inc (NASDAQ:PLCM), Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), Inteliquent Inc (NASDAQ:IQNT).
Keryx Biopharmaceuticals (NASDAQ:KERX), opened the session at $9.46, remained amid the day range of $9.36 - $9.95, and closed the session at $9.78. The stock showed a positive performance of 3.49% in previous trading session. The stock gained a volume of 1.52 million shares and the average volume of the stock remained 1.54 million shares.
Will KERX Continue To Move Higher? Find Out Here
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States.
Polycom Inc (NASDAQ:PLCM), traded with volume of 1.49 million shares in the prior session and the average volume of the stock remained 2.24 million shares. The 52 week range of the stock remained $9.00 - $11.94. The stock showed a negative movement of -0.18% and closed its session at $10.85. The market capitalization of the stock remained 1.84 billion.
Will PLCM Get Buyers Even After The Recent Rally? Find Out Here
Polycom, Inc. provides standards-based unified communications and collaboration (UC&C) solutions for voice and video collaboration.
Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), exchanged 1.48 million shares and the average volume remained 4.81 million shares. The stock escalated0.12 % and closed the session at $8.53. The beta of the stock remained 1.09 and the EPS of the stock remained -0.01.
Why Should Investors Buy ASTX After The Recent Gain Find Out Here
Astex Pharmaceuticals, Inc. engages in the discovery and development of small molecule therapeutics with a focus on oncology and hematology using its fragment-based drug discovery platform, Pyramid.
Inteliquent Inc (NASDAQ:IQNT) traded with volume of 1.45 million shares and the average volume of the stock remained 669,889 shares. The stock grew7.99 % and finished the trading at $9.19. The market capitalization of the stock remained 297.08 million. The beta of the stock remained 0.95.
Will IQNT Continue To Move Higher? Find Out Here
Inteliquent Inc. provides voice, Internet protocol (IP) transit, and Ethernet telecommunications services primarily on a wholesale basis in the United States and internationally.
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)